Daniel Pasin

Daniel Pasin

Founder & Developer @ Hyperion Data

Publications

You can find these on:

Publication Summary

Journal# PublicationsImpact Factor†CiteScore‡
Analytical and Bioanalytical Chemistry13.87.9
Analytical Chemistry26.711.6
Analytical Chimica Acta16.010.4
Analytical Methods12.64.5
Archives of Toxicology16.910.0
Drug Testing and Analysis42.46.2
Forensic Science International22.54.6
Journal of Analytical Toxicology32.65.8
Journal of Hazardous Materials111.324.6
Nature Machine Intelligence123.937.6
iScience14.16.9
Total18  

† Journal Citation Reports 2024
‡ Scopus

2026

  1. Grafinger KE, Weinmann W, Pasin D, Gréen Henrik, Stove CP, Schöning V, Hammann F. (2026) Machine Learning in Forensic Toxicology: Concepts, Applications and Challenges in Bioanalysis, ADME, and Toxicodynamics. Forensic Science International. 112883. DOI 10.1016/j.forsciint.2026.112883.
  2. Swan S, Sarkisian M, Pasin D, Rodda LN. (2026) Applications of machine learning for the general unknown screening of HRMS data within forensic toxicology. Journal of Analytical Toxicology. DOI 10.1093/jat/bkaf109.

2024

  1. Gundersen POM, Pasin D, Slørdal L, Spigset O, Josefsson M. (2024) Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021. Forensic Science International. 361:112131. DOI 10.1016/j.forsciint.2024.112131.
  2. Bade R, van Herwerden D, Rousis N, Adhikari S, Allen D, Baduel C, Bijlsma L, Boogaerts T, Burgard D, Chappell A, Driver EM, Fabriz Sodre F, Fatta-Kassinos D, Garcia Lor E, Gracia-Marin E, U. Halden R, Heath E, Jaunay E, Krotulski A, Yin Lai F, Ching Love AS, O'Brien J, Oh J-E, Pasin D, Pineda M, Psichoudaiki M, Salgueiro-González N, Gomes CS, Subedi B, Thomas K, Thomaidis NS, Wang D, Yargeau V, Samanipour S, Mueller JF. (2024) Workflow to Facilitate the Detection of New Psychoactive Substances and Drugs of Abuse in Influent Urban Wastewater. Journal of Hazardous Materials. 469: 133955. DOI: 10.1016/j.jhazmat.2024.133955.

2023

  1. Wang F, Pasin D, Skinnider MA, Liigand J, Kleis JN, Brown D, Oler E, Sajed T, Gautam V, Harrison S, Greiner R, Foster LJ, Dalsgaard PW, Wishart D. (2023) Deep learning-enabled MS/MS spectrum prediction facilitates automated identification of novel psychoactive substances. Analytical Chemistry. 95(50): 18326–18334. DOI: 10.1021/acs.analchem.3c02413.
  2. Skinnider MA, Merette S, Pasin D, Rogalski J, Foster LJ, Scheuermeyer F, Shapiro A. (2023) Identification of emerging novel psychoactive substances by retrospective analysis of population-scale mass spectrometry datasets. Analytical Chemistry 95 (47): 17300-17310. DOI: 10.1021/acs.analchem.3c03451.
  3. Brown A, Lamb E, Deo A, Pasin D, Liu T, Zhang, W, Su S, Ueland M. (2023) The use of novel electronic nose technology to locate missing persons for criminal investigations. iScience, 26(4): 106353. DOI: 10.1016/j.isci.2023.106353.

2022

  1. Pasin D, Nedahl M, Mollerup CB, Tortzen C, Reitzel LA, Dalsgaard PW. (2022) Identification of the synthetic cannabinoid-type new psychoactive substance, CH-PIACA, in seized material. Drug Testing and Analysis, 14(9): 1645-51. DOI: 10.1002/dta.3333.
  2. Klingberg J, Keen B, Cawley A, Pasin D, Fu S. (2022) Developments in high-resolution mass spectrometric analyses of new psychoactive substances. Archives of Toxicology, 96: 949-67. DOI: 10.1007/s00204-022-03224-2.
  3. Pasin D, Pan M, Rasmussen BS, Linnet K, Dalsgaard PW, Mollerup CB. (2022) Metabolomics-driven determination of targets for salicylic acid and ibuprofen in positive electrospray ionization using LC-HRMS. Drug Testing and Analysis, 14(4): 747-56. DOI: 10.1002/dta.3215.

2021

  1. Skinnider M, Wang F, Pasin D, Greiner R, Foster L, Dalsgaard PW, Wishart DS. (2021) A deep generative model enables automated structure elucidation of novel psychoactive substances. Nature Machine Intelligence, 3, 973-984. DOI: 10.1038/s42256-021-00407-x.
  2. Pasin D, Mollerup CB, Rasmussen BS, Linnet K, Dalsgaard PW. (2021) Development of a single retention time prediction model integrating multiple liquid chromatography systems: Application to new psychoactive substances. Analytica Chimica Acta, 1184, 339035. DOI: 10.1016/j.aca.2021.339035.
  3. Klingberg J, Cawley A, Shimmon R, Fouracre C, Pasin D, Fu S. (2020) Finding the proverbial needle: Non-targeted screening of synthetic opioids in equine plasma, Drug Testing and Analysis, 13(5), 977-89. DOI: 10.1002/dta.2893.

2017

  1. Pasin D, Cawley A, Bidny S, Fu S. (2017) Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Analytical and Bioanalytical Chemistry, 409(25): 5821-36. DOI: 10.1007/s00216-017-0441-4.
  2. Pasin D, Cawley A, Bidny S, Fu S. (2017) Characterisation of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes. Drug Testing and Analysis, 9(10): 1620-9. DOI: 10.1002/dta.2171.
  3. Bidny S, Gago K, Chung P, Albertyn D, Pasin D. (2017) Simultaneous screening and quantification of basic, neutral and acidic drugs in blood using UPLC-QTOF-MS. Journal of Analytical Toxicology, 41(3): 181-95. DOI: 10.1093/jat/bkw118.

2016

  1. Cawley A, Pasin D, Ganbat N, Ennis L, Smart C, Greer C, Keledjian J, Fu S, Chen A. (2016) The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometry. Analytical Methods, 8(8): 1789-97. DOI: 10.1039/C6AY00156D.

2015

  1. Pasin D, Bidny S, Fu S. (2015) Analysis of new designer drugs in post-mortem blood using high resolution mass spectrometry. Journal of Analytical Toxicology, 39(3): 163-71. DOI: 10.1093/jat/bku144.